Simples. The whole biotech market is crap. Investors are still not returning, even for strong companies like Neuren and Telix. There are many biotech companies that have declined over the last 18 months, in US, UK, and ASX, after a strong run in the previous years. The tide will turn, I keep expecting it to be next week and am regularly disappointed, but for Neuren the case is compelling. Give it time.
Share Price, page-6175
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.65 |
Change
0.000(0.00%) |
Mkt cap ! $1.744B | |||
| Open | High | Low | Value | Volume |
| $13.70 | $13.76 | $13.56 | $3.689M | 270.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 37 | $13.60 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.66 | 1132 | 2 |
View Market Depth
| Last trade - 16.10pm 17/09/2024 (20 minute delay) ? |
| NEU (ASX) Chart |